Victoria Murphy

Array ( [id] => 4720091 [patent_doc_number] => 20080242614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING INFECTIONS USING ANALOGUES OF INDOLICIDIN' [patent_app_type] => utility [patent_app_number] => 12/058500 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26002 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242614.pdf [firstpage_image] =>[orig_patent_app_number] => 12058500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336784 [patent_doc_number] => 20090053248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Compositions and methods for transepithelial molecular transport' [patent_app_type] => utility [patent_app_number] => 12/079294 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 161 [patent_figures_cnt] => 161 [patent_no_of_words] => 30833 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12079294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846391 [patent_doc_number] => 20080182799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'BOTULINUM TOXIN SCREENING ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/047441 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 40834 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182799.pdf [firstpage_image] =>[orig_patent_app_number] => 12047441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579780 [patent_doc_number] => 20110293663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Pharmaceutical botulinum toxin compositions' [patent_app_type] => utility [patent_app_number] => 12/073245 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7394 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293663.pdf [firstpage_image] =>[orig_patent_app_number] => 12073245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069480 [patent_doc_number] => 09107815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Sustained release poloxamer containing pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 12/036139 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7177 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12036139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807769 [patent_doc_number] => 20080171347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'DETERMINING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN A PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/028633 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 118147 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171347.pdf [firstpage_image] =>[orig_patent_app_number] => 12028633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690154 [patent_doc_number] => 08389682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Inhibiting Staphylococcus epidermidis infections' [patent_app_type] => utility [patent_app_number] => 12/523425 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18662 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426499 [patent_doc_number] => 20100168203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ADENYLYL CYCLASES AS NOVEL TARGETS FOR ANTIBACTRIAL INTERVENTIONS' [patent_app_type] => utility [patent_app_number] => 12/523011 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15391 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168203.pdf [firstpage_image] =>[orig_patent_app_number] => 12523011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173552 [patent_doc_number] => 07658931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Mutant forms of cholera holotoxin as an adjuvant' [patent_app_type] => utility [patent_app_number] => 11/960226 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25620 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/658/07658931.pdf [firstpage_image] =>[orig_patent_app_number] => 11960226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227321 [patent_doc_number] => 20120141532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => ' Botulinum Toxin Formulation' [patent_app_type] => utility [patent_app_number] => 11/954629 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7190 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11954629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264462 [patent_doc_number] => 20090117147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'VACCINES COMPRISING OUTER MEMBRANE VESICLES FROM GRAM NEGATIVE BACTERIA' [patent_app_type] => utility [patent_app_number] => 11/949071 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 32758 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117147.pdf [firstpage_image] =>[orig_patent_app_number] => 11949071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410022 [patent_doc_number] => 20090123921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'IMMUNOGLOBULIN LIBRARIES' [patent_app_type] => utility [patent_app_number] => 11/948672 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 33298 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123921.pdf [firstpage_image] =>[orig_patent_app_number] => 11948672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241149 [patent_doc_number] => 20120149884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'SPECIFIC ANTIBODY SELECTION BY SELECTIVE ELUTION CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/943168 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10306 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11943168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280659 [patent_doc_number] => 20100119553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Helicobacter pylori sialic acid binding adhesin, SabA and sabA - gene' [patent_app_type] => utility [patent_app_number] => 11/983956 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6095 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119553.pdf [firstpage_image] =>[orig_patent_app_number] => 11983956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718668 [patent_doc_number] => 20080241190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'VACCINATION OF HORSES AGAINST LAWSONIA INTRACELLULARIS' [patent_app_type] => utility [patent_app_number] => 11/937657 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6687 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241190.pdf [firstpage_image] =>[orig_patent_app_number] => 11937657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916205 [patent_doc_number] => 20080096806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Compositions and methods for inhibiting microbial adhesion' [patent_app_type] => utility [patent_app_number] => 11/983007 [patent_app_country] => US [patent_app_date] => 2007-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9092 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096806.pdf [firstpage_image] =>[orig_patent_app_number] => 11983007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758903 [patent_doc_number] => 20080311129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'ADHERENCE INHIBITOR DIRECTED TO AND METHOD OF MAKING AND USING' [patent_app_type] => utility [patent_app_number] => 11/933778 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1799 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311129.pdf [firstpage_image] =>[orig_patent_app_number] => 11933778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733425 [patent_doc_number] => 20080050404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Pressure Sore Treatment' [patent_app_type] => utility [patent_app_number] => 11/932908 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13843 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050404.pdf [firstpage_image] =>[orig_patent_app_number] => 11932908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718669 [patent_doc_number] => 20080241191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies' [patent_app_type] => utility [patent_app_number] => 11/982410 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8850 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241191.pdf [firstpage_image] =>[orig_patent_app_number] => 11982410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954964 [patent_doc_number] => 20080187988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'CYTOPLASMIC ANTIGENS FOR DETECTION OF CANDIDA' [patent_app_type] => utility [patent_app_number] => 11/928632 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12420 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187988.pdf [firstpage_image] =>[orig_patent_app_number] => 11928632 [rel_patent_id] =>[rel_patent_doc_number] =>)